The risk factors for stroke in the South also may be responsible for cognitive decline.

Published in Focus on Patient Care

By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.

Published in Focus on Patient Care

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

Published in Focus on Patient Care

Sleep deprivation, stress and a confused circadian clock can be a lethal combination  

Page 5 of 5
Back to Top